Knockdown of the Bovine Leukemia Virus Tax Gene by RNAi and Its Effects on Host Gene Expression - PowerPoint PPT Presentation

1 / 18
About This Presentation
Title:

Knockdown of the Bovine Leukemia Virus Tax Gene by RNAi and Its Effects on Host Gene Expression

Description:

Knock-down of the Bovine Leukemia Virus Tax Gene by RNAi and Its Effects on Host ... Bovine Leukemia Virus (BLV) as a Model for Systems Biology of Retroviral ... – PowerPoint PPT presentation

Number of Views:503
Avg rating:3.0/5.0
Slides: 19
Provided by: elaines6
Category:

less

Transcript and Presenter's Notes

Title: Knockdown of the Bovine Leukemia Virus Tax Gene by RNAi and Its Effects on Host Gene Expression


1
Knock-down of the Bovine Leukemia Virus Tax Gene
by RNAi and Its Effects on Host Gene Expression
  • Rosane Oliveira, Allison Sommers, Robin Everts,
    Harris Lewin
  • ESALQ-UIUC Genomics Workshop
  • December 17th 2007 Piracicaba, Brazil

2
(Doolittle et al, 1990)
3
Genetic Map
(Retroviruses, 1997)
4
Bovine Leukemia Virus (BLV) as a Model for
Systems Biology of Retroviral Transformation of
Mammalian Cells
  • Features of the BLV Model System
  • BLV is a chronic transforming deltaretrovirus in
    same family as the HTLVs
  • BLV infects CD5 B cells and causes persistent
    lymphocytosis (pre-leukemic state) in 30 of
    infected animals (dependent on host class II DRB3
    genotype)
  • 1 develop lymphosarcoma (100 mortality)
  • Costs to US dairy industry at least 100
    million/year
  • Two-hit model of cell transformation
  • First Hit genome instability
  • Provirus integration (random)
  • Trans-activation/repression of host cell genes by
    BLV tax
  • Second Hit
  • Deletion and/or mutation of tumor suppressor
    genes
  • Chromosome rearrangements
  • Goal
  • To understand the role of BLV Tax in driving
    B-cell proliferation and leukemogenesis

Tumors
Persistent Lymphocytosis
Tumor
Seropositive (asymptomatic)
5
What Are the Host Cell Target Genes and
Biological Pathways that Are Affected by BLV Tax?
  • RNA interference (RNAi)
  • siRNA targeting Tax gene
  • Amaxa Nucleofector II
  • 2 cell lines (BL3º and BL3)
  • 6 biological replicates
  • 5-6 technical replicates per experiment
  • Tax- and Scrambled-siRNA 2 controls
  • Microarray
  • 13,245-element cattle-specific oligo array
  • (Loor et al., 2007)
  • Quantitative PCR
  • BLV Tax mRNA
  • Host cellular genes (validation of microarray
    results)
  • Data Mining
  • Ingenuity Pathway Analysis Metacore by GeneGO
    Inc.

6
What Are the Host Cell Target Genes and
Biological Pathways that Are Affected by BLV Tax?
  • RNA interference (RNAi)
  • siRNA targeting Tax gene
  • 2 cell lines (BL3º and BL3)
  • 6 Biological Replicates
  • 5-6 technical replicates
  • Tax- and Scrambled-siRNA
  • 2 controls
  • 4 Comparisons
  • BL3 scrambled-siRNA/BL3º scrambled-siRNA
  • BL3 tax-siRNA/BL3º tax-siRNA
  • BL3º tax-siRNA/BL3º scrambled-siRNA
  • BL3 tax-siRNA/BL3 scrambled-siRNA

Amaxa Nucleofector II
7
What Are the Host Cell Target Genes and
Biological Pathways that Are Affected by BLV Tax?
  • Transcription Profiling of Tax Knock-down
  • 13,245-element cattle-specific oligonucleotide
    array (Loor et al., 2007)
  • Direct comparison, 4 different comparisons
  • Loess normalization and data analysis with
    Genespring
  • Tested for differences in ratios using T-test
    Benjamini and Hochberg false discovery rate (FDR)
    for multiple testing correction (P-value lt 0.05)
  • Confirmation of DEG by Quantitative PCR
  • BLV Tax mRNA
  • Host cellular genes
  • CDK6, CLU, DNAJB6, DUSP1 (MPK1), NDUFA2, STAT1,
    BHLHB2 (DEC1), IL4R, MARCKS, PRKCD
  • Pathway Analysis and Modeling (Data Mining)
  • Ingenuity Pathway Analysis
  • GO and canonical pathways distributions
  • Metacore by GeneGO Inc.
  • Networks and pathways

8
Rationale of RNAi Knock-down of BLV Tax
9
Experimental Approach
Transcription Profile
BL3
Comparison I
Tax-siRNA
Scrambled-siRNA/ºScrambled-siRNA
RNA Isolation qPCR for Tax
Comparison II
Scrambled-siRNA
Tax-siRNA/Scrambled-siRNA
BL3º
Comparison III
Tax-siRNA
ºTax-siRNA/ºScrambled-siRNA
RNA Isolation qPCR for Tax
Scrambled-siRNA
Comparison IV
Tax-siRNA/ºTax-siRNA
10
Tax knock-down Assessed by qPCR
11
Results
Comparison I (Scrambled-Off Target) 3
Scrambled/3º Scrambled
Cell line-specific
4,057
1,694
908
Comparison IV (3 Tax-Off Target) 3 Tax/3º Tax
Benjamini Hochberg false discovery rate P lt0.20
12
Genome-wide Effects of RNAi Knock-down of BLV Tax
mRNA
  • Microarray analysis
  • 184 differentially expressed genes in BL3 cells
    treated with tax-siRNA

Benjamini Hochberg false discovery rate, P lt
0.2
13
Quantitative PCR Validation of 10 Host Genes
Affected by BLV Tax mRNA Knock-down








t-test, FDR Plt0.05 t-test, FDR Plt0.01
14
Canonical Pathways Affected by Knock-down of BLV
Tax mRNA in BL3 cells
15
Biological Functions Affected by Knock-down of
Tax mRNA in BL3 cells
16
Cell Death Gene Network
17
Model for Role of BLV in B-Cell Transformation
Apoptosis
Cell Cycle
BLV Tax
mRNA processing
Transcription
Viral replication
Protein biosynthesis, ribosome
Cellular Growth and Proliferation
Cell-Cell Signaling
New virions
18
Conclusions Future Directions
  • Critical pathways of cell growth and
    proliferation (e.g. cell signaling, cell cycle
    and cell death/apoptosis) are affected directly
    by BLV-tax (likely through STAT1).
  • The gene networks affected by tax knock-down
    provide strong evidence that BLV-tax creates
    mitotic instability in BLV-infected cells by
    disrupting normal processes of cell division.
  • We hypothesize that these tax-mediated effects on
    host gene transcription lead to the oligoclonal
    expansion of B cell precursor(s) and the onset of
    persistent lymphocytosis (PL).
  • Future studies will focus on direct
    identification of BLV-tax binding sites in the
    cattle genome (ChIP-PET). These studies will
    permit molecular dissection of the upstream
    transcription pathways that lead to mitotic
    instability and cell transformation in BLV
    infected cattle.
  • Understanding the molecular pathways leading to
    PL and lymphosarcoma may provide novel vaccine
    and therapeutic strategies for disease caused by
    BLV and HTLVs.

19
Acknowledgments
Prof. Harris A. Lewin
Dr. Robin E. Everts
Allison M. Sommers
Write a Comment
User Comments (0)
About PowerShow.com